Cowpea protein reduces LDL-cholesterol and apolipoprotein b concentrations, but does not improve biomarkers of inflammation or endothelial dysfunction in adults with moderate hypercholesterolemia;Proteína caupí reduce las concentraciones de LDL-colesterol y apolipoproteína B, pero no mejora biomarcadores inflamatorios y disfunción endotelial en adultos con hipercolesterolemia moderada

Nutricion Hospitalaria

Volumn 31, Issue 4, 2015, Pages 1611-1619

  Frota, Karoline de Macêdo Gonçalves ^a   dos Santos, Raul Dias ^b   Ribeiro, Valdenir Queiroz ^c   Arêas, José Alfredo Gomes ^b  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c EMBRAPA CERRADOS   (Brazil)

Author keywords

Apolipoproteins; Cholesterol; Cowpea; Inflammation; Plant proteins

Indexed keywords

ANIMALIA; CRICETINAE; PERO;

APOLIPOPROTEIN B; AUTACOID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN INTAKE;

ADULT; AGED; BLOOD; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; THERAPEUTIC USE; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM; VIGNA;

ADULT; AGED; APOLIPOPROTEINS B; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; CROSS-OVER STUDIES; DIETARY PROTEINS; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INFLAMMATION; INFLAMMATION MEDIATORS; LIPIDS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VIGNA;

EID: 84925353336     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2015.31.4.8457     Document Type: Article

References (35)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ et al. Heart disease and stroke statistics - 2014 update: a report from the American heart association. Circulation 2014;129: 399-410.
2. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285: 2486-2427.
3. Anderson TJ, Grégoire J, Hegele RA, Couture P, Mancini J, McPherson R, et al. 2012 Update of the Canadian cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Can J Cardiol 2013; 29: 151-167.
4. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB et al. Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004; 44: 720-732.
5. Hill AM, Fleming JA, Kris-Etherton PM. The role of diet and nutritional supplements in preventing and treating cardiovascular disease. Curr Opin Cardiol 2009; 24: 433-441.
6. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54(23): 2129-2138.
7. Pasceri V, Willerson JT, Yeh ETH. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168.
8. Willerson JT. Systemic and local inflammation in patients with unstable atherosclerotic plaques. Prog Cardiovasc Dis 2002; 44:469-478.
9. Bouchenak M, Lamri-Senhadji M. Nutritional quality of legumes, and their role in cardiometabolic risk prevention: a review. J Med Food 2013; 16(3): 185-198.
10. Anderson JW, Major AW. Pulses and lipaemia, short- and long term effect: potential in the prevention of cardiovascular disease. Br J Nutr 2002; 88: S263-S271.
11. Tovar J, Nilsson A, Johansson M, Björck I. Combining functional features of whole-grain barley and legumes for dietary reduction of cardiometabolic risk: a randomised cross-over intervention in mature women. Br J Nutr 2014; 111(4): 706-714.
12. Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr 2005; 81: 397-408.
13. Frota KMG, Mendonça S, Saldiva PHN, Cruz RJ, Arêas JAG. Cholesterol-lowering properties of whole cowpea seed and its protein isolate in hamsters. J Food Sci 2008; 73: 235-240.
14. Mendonça S, Saldiva PH, Cruz RJ, Arêas JAG. Amaranth protein presents cholesterol-lowering effect. Food Chem 2009; 116: 738-742.
15. Friedewald WT, Fredrick DS, Levy RI. Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge Clin Chem 1972; 18:499-502.
16. Unifesp. Programa de Apoio a Nutrição – NutWin [software]. Departamento de Informática em Saúde. Universidade Federal de São Paulo; 2005.
17. Singer JM, Andrade DF. Analysis of longitudinal data. Handbook of Statistics. In: Sen PK, Rao CR (eds). Bio-Environmental and Public Health Statistics. Amsterdam: North Holland 2000, pp.115-160.
18. SAS Institute (Cary. NC). SAS/STAT: user`s guide, version 8.1. v-1, 943p. Cary 2000.
19. Quin FM. Introduction. In: Sing BB, Mohan RAJ, Dashiel KE, Jackai LEN (Eds). Advances in cowpea research. Ibadan: IITA-JIRCAS, 1997, p. 9-15.
20. Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipid. N Engl J Med 1995; 333: 276-282.
21. Reynolds K, Chin A, Lees KA, Nguyen A, Bujnowski D, He J. A meta-analysis of the effect of soy protein supplementation on serum lipids. Am J Cardiol 2006; 98: 633-640.
22. Borodin EA, Menshikova IG, Dorovskikh VA, Feoktistova NA, Shtarberg MA, Yamamoto T et al. Effects of two-month consumption on 30g a day of soy protein isolate or skimmed curd protein on blood lipid concentration in Russian adults with hyperlipidemia. J Nutr Sci Vitaminol 2009; 55:492-497.
23. Maki KC, Butteiger DN, Rains TM, Lawless A, Reeves MS, Schasteen C et al. Effects of soy protein on lipoprotein lipids and fecal bile acid excretion in men and women with moderate hypercholesterolemia. J Clinical Lipidology 2010; 4: 531-542.
24. Anderson JW, Bush HM. Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. J Am Coll Nutr 2011; 30:79-91.
25. Cholesterol Treatment Trialists’ (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet 2010; 376:1670-1681.
26. Brown BG, Stukovsky KH, Zhao XQ. Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials. Curr Opin Lipidol 2006; 17:631-636.
27. Robinson JG, Wang S, Smith BJ, Jacobson TA. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J Am Coll Cardiol. 2009; 53:316-322.
28. Cho SJ, Juillerat MA, Lee CH. Identification of LDL-recep-tor transcription stimulating peptides from soybean hydrolysate in human hepatocytes. J Agric Food Chem 2008; 56: 4372-4376.
29. Marques MR, Freitas RAMS, Carlos ACC, Siguemoto ES, Fontanari GG, Arêas JAG Peptides from cowpea present an-tioxidant activity, inhibit cholesterol synthesis and its solubilisation into micelles. Food Chemistry 2015; 168: 288-293.
30. Nes WD. Biosynthesis of cholesterol and other sterols. Chemical Reviews 2011; 111: 6423-6451.
31. Rebholz CM, Reynolds K, Wofford MR, Chen J, Kelly TN, Mei H et al. Effect of soybean protein on novel cardiovascular disease risk factors: a randomized controlled trial. Eur J Clin Nutr 2012; 67:58-63.
32. Campbell CG, Brown BD, Dufner D, Thorland WG. Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men. Lipids 2006; 41: 257-265.
33. Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS. Consumption of isoflavone-rich soy protein does not alter homocysteine or markers of inflammation in postmenopausal women. Eur J Clin Nutr 2008; 62:1419-1425.
34. Liu ZM, Ho SC, Chen YM, Woo J. Effect of soy protein and isoflavones on blood pressure and endothelial cytokines: a 6-month randomized controlled trial among postmenopausal women. J Hypertens 2013;31:384-392.
35. Register T, Cann J, Kaplan J, Williams J, Adams M, Morgan T et al. Effects of soy isoflavones and conjugated equine estrogens on inflammatory markers in atherosclerotic, ovariectomized monkeys. J Clin Endocrinol Metab 2005; 90:1734-1740.